Trends in gynecologic cancer among elderly women in Denmark, 1980–2012
暂无分享,去创建一个
Ole Mogensen | O. Mogensen | J. Herrstedt | Anja Ør Knudsen | Doris Schledermann | Gitte-Bettina Nyvang | Jørn Herrstedt | D. Schledermann | G. Nyvang | A. Ør Knudsen
[1] S. Kjaer,et al. Ovarian cancer incidence and mortality in denmark, 1943‐1982 , 1988, International journal of cancer.
[2] Paul W Dickman,et al. Regression models for relative survival , 2004, Statistics in medicine.
[3] K. Frederiksen,et al. Cervical cancer incidence in Denmark over six decades (1943–2002) , 2006, Acta obstetricia et gynecologica Scandinavica.
[4] R. Cress,et al. Declining trends of epithelial ovarian cancer in California. , 2008, Gynecologic oncology.
[5] B. Monk,et al. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] J. Hallas,et al. Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients. , 2012, Gynecologic oncology.
[7] V. Beral,et al. Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies , 2015, The Lancet.
[8] E. Miyagi,et al. Radiation Therapy for Very Elderly Patients Aged 80 Years and Older With Squamous Cell Carcinoma of the Uterine Cervix , 2017, American journal of clinical oncology.
[9] Michael W Sill,et al. Improved survival with bevacizumab in advanced cervical cancer. , 2014, The New England journal of medicine.
[10] B. Ottesen,et al. Centralized treatment of advanced stages of ovarian cancer improves survival: a nationwide Danish survey , 2010, Acta obstetricia et gynecologica Scandinavica.
[11] T. Bauknecht,et al. A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer. , 2003, Journal of the National Cancer Institute.
[12] Nicolas Wentzensen,et al. Metabolic Syndrome and Risk of Endometrial Cancer in the United States: A Study in the SEER–Medicare Linked Database , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[13] S. Alam,et al. The Cigarette Smoke Carcinogen Benzo[a]pyrene Enhances Human Papillomavirus Synthesis , 2007, Journal of Virology.
[14] K. Christensen,et al. Trends in cancer in the elderly population in Denmark, 1980–2012 , 2016, Acta oncologica.
[15] K. Scher,et al. Under-representation of older adults in cancer registration trials: known problem, little progress. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] A. Mitsuhashi,et al. Daily Low-Dose Cisplatin-Based Concurrent Chemoradiotherapy for the Treatment of Cervical Cancer in Patients 70 Years or Older , 2015, International Journal of Gynecologic Cancer.
[17] T. Whelan,et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis , 2009, The Lancet.
[18] E. Partridge,et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer , 1996, New England Journal of Medicine.
[19] U. Menon,et al. Ovarian cancer screening—Current status, future directions☆ , 2014, Gynecologic oncology.
[20] M. Johnston,et al. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer: a meta-analysis. , 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).
[21] Paul Symonds,et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis , 2001, The Lancet.